Role of lymphangiogenic factors in tumor metastasis

被引:158
作者
He, YL
Karpanen, T
Alitalo, K
机构
[1] Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Ludwig Inst Canc Res, Biomedicum Helsinki, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2004年 / 1654卷 / 01期
基金
美国国家卫生研究院;
关键词
VEGFR-3; lymphangiogenesis; tumor metastasis;
D O I
10.1016/j.bbcan.2003.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nearly four centuries after the discovery of lymphatic vessels, the molecular mechanisms underlying their development are beginning to be elucidated. Vascular endothelial growth factor C (VEGF-C) and VEGF-D, via signaling through VEGFR-3, appear to be essential for lymphatic vessel growth. Observations from clinicopathological studies have suggested that lymphatic vessels serve as the primary route for the metastatic spread of tumor cells to regional lymph nodes. Recent studies in animal models have provided convincing evidence that tumor lymphangiogenesis facilitates lymphatic metastasis. However, it is not clear how tumor-associated lymphangiogenesis is regulated, and little is known about how tumor cells escape from the primary tumor and gain entry into the lymphatics. This review examines some of these issues and provides a brief summary of the recent developments in this field of research. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 113 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]   Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues [J].
Akagi, K ;
Ikeda, Y ;
Miyazaki, M ;
Abe, T ;
Kinoshita, J ;
Maehara, Y ;
Sugimachi, K .
BRITISH JOURNAL OF CANCER, 2000, 83 (07) :887-891
[3]   Molecular mechanisms of lymphangiogenesis in health and disease [J].
Alitalo, K ;
Carmeliet, P .
CANCER CELL, 2002, 1 (03) :219-227
[4]   Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa [J].
Amioka, T ;
Kitadai, Y ;
Tanaka, S ;
Haruma, K ;
Yoshihara, M ;
Yasui, W ;
Chayama, K .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (10) :1413-1419
[5]   Clinical significance of vascular, endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma [J].
Arinaga, M ;
Noguchi, T ;
Takeno, S ;
Chujo, M ;
Miura, T ;
Uchida, Y .
CANCER, 2003, 97 (02) :457-464
[6]   Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1 [J].
Ayadi, A ;
Zheng, H ;
Sobieszczuk, P ;
Buchwalter, G ;
Moerman, P ;
Alitalo, K ;
Wasylyk, B .
EMBO JOURNAL, 2001, 20 (18) :5139-5152
[7]   LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan [J].
Banerji, S ;
Ni, J ;
Wang, SX ;
Clasper, S ;
Su, J ;
Tammi, R ;
Jones, M ;
Jackson, DG .
JOURNAL OF CELL BIOLOGY, 1999, 144 (04) :789-801
[8]  
Beasley NJP, 2002, CANCER RES, V62, P1315
[9]   Interstitial flow as a guide for lymphangiogenesis [J].
Boardman, KC ;
Swartz, MA .
CIRCULATION RESEARCH, 2003, 92 (07) :801-808
[10]   TUMOR NECROSIS CAN FACILITATE THE APPEARANCE OF METASTASES [J].
BONFIL, RD ;
BUSTUOABAD, OD ;
RUGGIERO, RA ;
MEISS, RP ;
PASQUALINI, CD .
CLINICAL & EXPERIMENTAL METASTASIS, 1988, 6 (02) :121-129